Studi terkait mortalitas akibat kanker, khususnya di tingkat lokal, seperti provinsi, masih terbatas dan sebagian besar berfokus pada morbiditas atau prevalensi. Penelitian ini bertujuan untuk menganalisis tren mortalitas akibat kanker di Jakarta pada tahun 2017, 2019, 2021, dan 2023 menggunakan desain potong lintang dengan data dari Dinas Kesehatan Provinsi Jakarta. Analisis univariat dilakukan untuk mengevaluasi tren mortalitas berdasarkan tahun, kelompok usia, jenis kelamin, wilayah, dan sumber pelaporan fasilitas kesehatan. Hasil penelitian menunjukkan perubahan peringkat kanker utama, di mana kanker trakea, bronkus, dan paru-paru, yang menjadi penyebab kematian tertinggi pada 2017, digantikan oleh kanker payudara mulai 2019. CSDR (Cause Specific Death Rate) kanker utama meningkat sejak 2017, menurun pada 2021, lalu mencapai puncaknya pada 2023. Mortalitas tertinggi terjadi pada kelompok lansia (43,9% – 44,6%) dan dewasa paruh baya (42,8% – 44,7%), dengan perempuan (52,0% – 57,7%) lebih banyak terdampak dibandingkan laki-laki (42,3% – 48%). Jakarta Timur melaporkan mortalitas tertinggi (27,9% – 30,8%), diikuti Jakarta Barat (20,9% – 26,7%), dengan rumah sakit sebagai sumber pelaporan utama (66,2% – 83,7%). Kasus-kasus tereksklusi dalam penelitian ini mencerminkan tantangan dalam pengumpulan dan pencatatan data yang akurat. Penelitian ini menekankan pentingnya peningkatan kualitas data untuk mendukung kebijakan dan intervensi yang lebih efektif dalam mengurangi beban mortalitas akibat kanker.

Studies related to cancer mortality, especially at the local level, such as provinces, are still limited and mostly focus on morbidity or prevalence. This study aims to analyze cancer mortality trends in Jakarta in 2017, 2019, 2021, and 2023 using a cross-sectional design with data from the Jakarta Provincial Health Office. Univariate analysis was conducted to evaluate mortality trends based on year, age group, gender, region, and the reporting source from healthcare facilities. The results show a change in the ranking of major cancers, where tracheal, bronchial, and lung cancer, which was the leading cause of death in 2017, was replaced by breast cancer starting in 2019. The Cause-Specific Death Rate (CSDR) for major cancers increased since 2017, decreased in 2021, and then peaked in 2023. The highest mortality occurred in the elderly group (43.9% – 44.6%) and middle-aged adults (42.8% – 44.7%), with women (52.0% – 57.7%) being more affected than men (42.3% – 48%). East Jakarta reported the highest mortality (27.9% – 30.8%), followed by West Jakarta (20.9% – 26.7%), with hospitals as the primary reporting source (66.2% – 83.7%). Cases excluded from this study reflect challenges in the collection and recording of accurate data. This study emphasizes the importance of improving data quality to support policies and interventions that are more effective in reducing the cancer mortality burden.

Infeksi Hantavirus di Indonesia umumnya bermanifestasi sebagai Hemorrhagic Fever with Renal Syndrome (HFRS). Meskipun bukti reservoir pada rodensia cukup kuat, data epidemiologis pada manusia masih terbatas. Mendeskripsikan karakteristik epidemiologi kasus konfirmasi Hantavirus di Indonesia tahun 2025 berdasarkan aspek orang, tempat, dan waktu. Studi kuantitatif dengan desain case series menggunakan data sekunder hasil penyelidikan epidemiologi Kementerian Kesehatan RI terhadap 14 kasus konfirmasi. Mayoritas kasus ditemukan pada laki-laki (71,43%) dan kelompok usia 19-59 tahun (50%). Jenis pekerjaan terbanyak adalah buruh/sopir/ART (35,71%). Gejala klinis dominan meliputi demam (85,71%) dan ikterik (64,28%), dengan 50% kasus mengalami komplikasi gagal ginjal. Sebagian besar kasus (92,86%) melaporkan keberadaan tikus di lingkungan tempat tinggal. Secara geografis, frekuensi tertinggi ditemukan di Provinsi DIY (42,85%). Berdasarkan waktu, puncak temuan kasus terjadi pada bulan Mei dan Juni. Kasus Hantavirus di Indonesia tahun 2025 ditemukan pada kelompok usia produktif dengan riwayat keberadaan reservoir di lingkungannya serta manifestasi klinis yang mengarah pada gangguan fungsi ginjal.

Hantavirus infection in Indonesia generally manifests as Hemorrhagic Fever with Renal Syndrome (HFRS). While evidence in rodent reservoirs is substantial, human epidemiological data remains limited. To describe the epidemiological characteristics of confirmed Hantavirus cases in Indonesia in 2025 based on person, place, and time. A quantitative study with a case series design using secondary data from the Indonesian Ministry of Health's epidemiological investigations of 14 confirmed cases. The majority of cases were found in males (71.43%) and the 19-59 age group (50%). The most frequent occupations were laborers/drivers/domestic workers (35.71%). Dominant clinical symptoms included fever (85.71%) and jaundice (64.28%), with 50% of cases experiencing renal failure complications. Most cases (92.86%) reported the presence of rats in their residential environment. Geographically, the highest frequency was in the Special Region of Yogyakarta (42.85%). Temporally, the peak of case findings occurred in May and June. Hantavirus cases in Indonesia in 2025 were identified in the productive age group with a history of reservoir presence in their environment and clinical manifestations leading to renal dysfunction.

Penelitian terkait premature mortality yaitu kematian usia 30-70 tahun akibat PTM di Indonesia masih terbatas. Penelitian bertujuan menganalisis tren premature mortality akibat 4NCD, meliputi kardiovaskular (CVD), kanker, diabetes, dan respirasi kronis (CRD) di DKI Jakarta tahun 2020-2024 menggunakan desain potong lintang berdasarkan data sekunder Dinas Kesehatan DKI Jakarta. Analisis univariat mengkaji tren premature mortality 4NCD berdasarkan distribusi umur, jenis kelamin, wilayah domisili, dan laporan fasilitas kesehatan. Hasil penelitian menyatakan premature mortality 4NCD diakibatkan CVD (78%), diabetes (17%), kanker (14%), dan CRD (9%). Kematian CVD disebabkan blok penyakit jantung lain (47,4%) dan serebrovaskular (19,4%). Kanker ganas primer di lokasi spesifik (88,7%), DM tipe 2 (77%). Kematian CRD didominasi blok penyakit lain pada sistem pernapasan (34%) dan penyakit pernapasan bawah kronis (27,8%). Premature mortality tertinggi terjadi di usia dewasa paruh baya (49%), lansia muda (46%), dan dewasa muda (5%). Kematian laki-laki (58%) lebih tinggi daripada perempuan (42%). Domisili angka kematian tertinggi terjadi di Jakarta Timur (30%), Jakarta Selatan (19%), Jakarta Utara (17%), dengan sumber laporan tertinggi puskesmas (56%). Kasus kematian tidak spesifik menggambarkan tantangan proses surveilans yang akurat. Penelitian ini menitikberatkan vitalitas kualitas data sebagai penunjang intervensi dan kebijakan yang efektif dan tepat sasaran dalam mengurangi morbiditas dan mortalitas PTM.

---

Research related to premature mortality, deaths aged 30-70 years due to NCDs in Indonesia, is still limited. This study aims to analyze the trend of premature mortality due to 4NCD, including CVD, cancer, diabetes, and CRD in DKI Jakarta in 2020-2024 using a cross-sectional design based on secondary data from DKI Jakarta Health Department. Univariate analysis examined 4NCD premature mortality trends based on age distribution, gender, domicile area, and health facility reports. The results showed 4NCD premature mortality was caused by CVD (78%), diabetes (17%), cancer (14%), and CRD (9%). CVD mortality due to other heart disease (47.4%) and cerebrovascular (19.4%). Site-specific primary malignant cancer (88.7%), type 2 DM (77%). CRD mortality by other respiratory system disease block (34%) and chronic lower respiratory disease (27.8%). Premature mortality was highest in middle-aged adults (49%), young elderly (46%), young adults (5%). Male mortality (58%) was higher than female mortality (42%). Domicile of death was highest in East Jakarta (30%), South Jakarta (19%), North Jakarta (17%), the highest source of report being puskesmas (56%). Unspecified death cases illustrate the challenges of accurate surveillance processes. This study emphasizes the vitality of data quality to support effective and targeted interventions and policies in reducing morbidity.

Penyakit tidak menular (PTM) merupakan masalah kesehatan utama sehingga deteksi dini melalui program skrining menjadi strategi penting. Namun, pemetaan capaian dan pola faktor risiko hasil skrining PTM di Provinsi Jakarta masih terbatas. Penelitian ini bertujuan mendeskripsikan program skrining PTM di Provinsi Jakarta tahun 2020-2024 menurut tahun, jenis kelamin, dan wilayah kota di Provinsi Jakarta tahun 2020–2024. Studi menggunakan desain epidemiologi deskriptif dengan rancangan ekologi berbasis data agregat Dinas Kesehatan Provinsi Jakarta menurut tahun, jenis kelamin, dan lima wilayah kota. Hasil menunjukkan capaian skrining meningkat tajam dari 38,8% (2020) menjadi 99,1% (2021), mencapai 100% (2022), dan melampaui 100% pada 2023–2024 (100,4% dan 101,4%). Jumlah peserta skrining juga naik dari 2.746.144 (2020) menjadi 7.865.422 (2024), dengan mayoritas peserta perempuan (53,5%–56,1%). Tiga faktor risiko terbanyak secara konsisten adalah obesitas sentral, obesitas, dan tekanan darah tinggi. Pada 2024, proporsi obesitas sentral mencapai 45,5%, diikuti obesitas 32,0% dan tekanan darah tinggi 25,2%, dengan pola tiga faktor risiko teratas yang relatif serupa di seluruh wilayah kota. Penelitian ini menyimpulkan bahwa obesitas sentral dan obesitas masih tinggi di Provinsi Jakarta sehingga diperlukan penguatan intervensi promotif–preventif yang lebih terarah menurut kelompok sasaran dan wilayah.

Non-communicable diseases (NCDs) represent a major public health concern; therefore, early detection through screening programmes is a critical strategy. However, evidence mapping screening coverage and the patterns of NCD risk factors identified through screening in Jakarta Province remains limited. This study aimed to describe the NCD screening programme in Jakarta Province from 2020 to 2024 by year, sex, and municipal area. A descriptive epidemiological study with an ecological design was conducted using aggregated data from the Jakarta Provincial Health Office by year, sex, and five municipal areas. The results showed that screening coverage increased sharply from 38.8% (2020) to 99.1% (2021), reached 100% (2022), and exceeded 100% in 2023–2024 (100.4% and 101.4%). The number of individuals screened also increased from 2,746,144 (2020) to 7,865,422 (2024), with females comprising the majority of participants (53.5%–56.1%). The three most frequently identified risk factors were consistently central obesity, obesity, and hypertension. In 2024, the proportion of central obesity reached 45.5%, followed by obesity at 32.0% and hypertension at 25.2%, with a broadly similar pattern of the top three risk factors across all municipal areas. The study concludes that central obesity and obesity remain high in Jakarta Province, underscoring the need to strengthen more targeted health promotion and preventive interventions by population group and area.